145 related articles for article (PubMed ID: 17391696)
1. Identification of a novel isoform of iASPP and its interaction with p53.
Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
[TBL] [Abstract][Full Text] [Related]
2. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.
Slee EA; Gillotin S; Bergamaschi D; Royer C; Llanos S; Ali S; Jin B; Trigiante G; Lu X
Oncogene; 2004 Dec; 23(56):9007-16. PubMed ID: 15489900
[TBL] [Abstract][Full Text] [Related]
3. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
Bergamaschi D; Samuels Y; O'Neil NJ; Trigiante G; Crook T; Hsieh JK; O'Connor DJ; Zhong S; Campargue I; Tomlinson ML; Kuwabara PE; Lu X
Nat Genet; 2003 Feb; 33(2):162-7. PubMed ID: 12524540
[TBL] [Abstract][Full Text] [Related]
4. siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.
Liu H; Wang M; Diao S; Rao Q; Zhang X; Xing H; Wang J
Leuk Res; 2009 Sep; 33(9):1243-8. PubMed ID: 19299014
[TBL] [Abstract][Full Text] [Related]
5. The expression of iASPP in acute leukemias.
Zhang X; Wang M; Zhou C; Chen S; Wang J
Leuk Res; 2005 Feb; 29(2):179-83. PubMed ID: 15607367
[TBL] [Abstract][Full Text] [Related]
6. Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells.
Liu ZJ; Cai Y; Hou L; Gao X; Xin HM; Lu X; Zhong S; Gu SZ; Chen J
Cancer Invest; 2008 Nov; 26(9):878-82. PubMed ID: 18798069
[TBL] [Abstract][Full Text] [Related]
7. The ASPP interaction network: electrostatic differentiation between pro- and anti-apoptotic proteins.
Benyamini H; Friedler A
J Mol Recognit; 2011; 24(2):266-74. PubMed ID: 20623514
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells.
Zhang B; Xiao HJ; Chen J; Tao X; Cai LH
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):219-24. PubMed ID: 21625267
[TBL] [Abstract][Full Text] [Related]
9. A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53.
Qiu S; Cai Y; Gao X; Gu SZ; Liu ZJ
Cancer Lett; 2015 Jan; 356(2 Pt B):910-7. PubMed ID: 25444901
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking analysis of the protein-protein interaction between RelA-associated inhibitor and tumor suppressor protein p53 and its inhibitory effect on p53 action.
Tomoda K; Takahashi N; Hibi Y; Asamitsu K; Ishida H; Kondo T; Fujii Y; Okamoto T
Cancer Sci; 2008 Mar; 99(3):615-22. PubMed ID: 18201273
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP.
Li S; Shi G; Yuan H; Zhou T; Zhang Q; Zhu H; Wang X
Oncol Rep; 2012 Jul; 28(1):133-40. PubMed ID: 22552744
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-κB activation, in hepatocellular carcinoma.
Lu B; Guo H; Zhao J; Wang C; Wu G; Pang M; Tong X; Bu F; Liang A; Hou S; Fan X; Dai J; Wang H; Guo Y
Gastroenterology; 2010 Dec; 139(6):2183-2194.e5. PubMed ID: 20600029
[TBL] [Abstract][Full Text] [Related]
13. Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9.
Arai S; Matsushita A; Du K; Yagi K; Okazaki Y; Kurokawa R
FEBS Lett; 2007 Dec; 581(29):5649-57. PubMed ID: 18022393
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins.
Skene-Arnold TD; Luu HA; Uhrig RG; De Wever V; Nimick M; Maynes J; Fong A; James MN; Trinkle-Mulcahy L; Moorhead GB; Holmes CF
Biochem J; 2013 Feb; 449(3):649-59. PubMed ID: 23088536
[TBL] [Abstract][Full Text] [Related]
15. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2).
Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E
J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
17. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
18. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.
Cen B; Deguchi A; Weinstein IB
Cancer Res; 2008 Jul; 68(13):5355-62. PubMed ID: 18593937
[TBL] [Abstract][Full Text] [Related]
19. The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions.
Edwards SJ; Hananeia L; Eccles MR; Zhang YF; Braithwaite AW
Oncogene; 2003 Jul; 22(29):4517-23. PubMed ID: 12881708
[TBL] [Abstract][Full Text] [Related]
20. p53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation.
Sun WT; Hsieh PC; Chiang ML; Wang MC; Wang FF
Biochem Biophys Res Commun; 2008 Nov; 376(2):395-8. PubMed ID: 18793611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]